Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
HTGM HTG Molecular Diagnostics, Inc. daily Stock Chart
HTGM [NASD]
HTG Molecular Diagnostics, Inc.
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
Index- P/E- EPS (ttm)-3.00 Insider Own2.50% Shs Outstand11.47M Perf Week3.37%
Market Cap21.10M Forward P/E- EPS next Y-1.72 Insider Trans-84.22% Shs Float8.90M Perf Month-10.24%
Income-23.80M PEG- EPS next Q-0.52 Inst Own22.90% Short Float19.56% Perf Quarter-32.85%
Sales5.50M P/S3.84 EPS this Y27.20% Inst Trans-16.34% Short Ratio3.81 Perf Half Y-80.93%
Book/sh-0.16 P/B- EPS next Y24.90% ROA-131.10% Target Price5.00 Perf Year-23.65%
Cash/sh1.17 P/C1.57 EPS next 5Y- ROE468.90% 52W Range1.20 - 13.25 Perf YTD-17.86%
Dividend- P/FCF- EPS past 5Y- ROI-164.50% 52W High-86.64% Beta-
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin11.10% 52W Low47.50% ATR0.18
Employees87 Current Ratio1.60 Sales Q/Q-5.30% Oper. Margin- RSI (14)41.01 Volatility9.63% 10.44%
OptionableNo Debt/Eq- EPS Q/Q38.80% Profit Margin- Rel Volume0.72 Prev Close1.84
ShortableYes LT Debt/Eq- EarningsAug 08 AMC Payout- Avg Volume456.36K Price1.77
Recom1.50 SMA20-3.99% SMA50-15.61% SMA200-40.01% Volume84,691 Change-3.80%
May-16-17Reiterated Rodman & Renshaw Buy $4.50 → $6
Aug-22-16Initiated Rodman & Renshaw Buy $5
Apr-04-16Reiterated Canaccord Genuity Buy $10 → $7
Nov-24-15Reiterated Canaccord Genuity Buy $12 → $10
Aug-24-15Reiterated Canaccord Genuity Buy $17 → $12
Jun-03-15Initiated JMP Securities Mkt Outperform
Jun-02-15Initiated Leerink Partners Outperform $18
Jun-02-15Initiated Canaccord Genuity Buy $17
Sep-25-17 08:00AM  HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-21-17 01:57PM  Should You Have HTG Molecular Diagnostics Incs (HTGM) In Your Portfolio? Simply Wall St. -5.64%
Sep-20-17 08:00AM  HTG Announces Issuance of Two Method Patents Related to its Technology GlobeNewswire +5.98%
Sep-18-17 08:00AM  HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements GlobeNewswire
Sep-11-17 08:00AM  HTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus Assay GlobeNewswire
Sep-06-17 08:00AM  HTG Molecular Diagnostics to Present at the Rodman & Renshaw 19th Annual Investment Conference GlobeNewswire -7.07%
Sep-05-17 08:00AM  Today's Research Reports on Trending Tickers: DryShips Inc. and Seadrill Ltd. ACCESSWIRE
Aug-31-17 06:49PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 31, 2017 Capital Cube
Aug-25-17 10:38AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
Aug-09-17 03:43PM  Edited Transcript of HTGM earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
08:00AM  HTG Molecular Diagnostics Technology to be Used in WIN Consortium NSCLC Clinical Trial GlobeNewswire
Aug-08-17 04:01PM  HTG Molecular Diagnostics Reports Second Quarter 2017 Results GlobeNewswire
10:30AM  Investor Network: HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 08:26PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 4, 2017 Capital Cube
Jul-27-17 09:00AM  HTG Molecular Diagnostics Announces Second Companion Diagnostic Development Project with QIAGEN GlobeNewswire
Jul-26-17 04:01PM  HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference GlobeNewswire
Jul-18-17 04:01PM  HTG Molecular Diagnostics to Hold 2017 Second Quarter Financial Results Conference Call on August 8, 2017 GlobeNewswire -8.36%
Jun-28-17 04:01PM  HTG Molecular Diagnostics Launches its HTG EdgeSeq PATH Assay GlobeNewswire +12.18%
Jun-26-17 08:00AM  HTG Molecular Diagnostics Participating in WIN 2017 Symposium GlobeNewswire
Jun-22-17 08:00AM  HTG Molecular New Technology, Financials, and Price Targets Accesswire
Jun-20-17 03:01PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : June 20, 2017 Capital Cube
Jun-16-17 08:00AM  Today's Research Reports on Stocks to Watch: HTG Molecular Diagnostics and Interpace Diagnostics Group Accesswire -9.62%
Jun-05-17 08:00AM  HTG Molecular Diagnostics Expands Its IVD Agreement With Illumina to Increase the Number of Test Kits GlobeNewswire
May-19-17 10:34AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube
May-16-17 04:43PM  Edited Transcript of HTGM earnings conference call or presentation 15-May-17 8:30pm GMT Thomson Reuters StreetEvents
12:53PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : May 16, 2017 Capital Cube
May-15-17 04:01PM  HTG Molecular Diagnostics Reports First Quarter 2017 Results GlobeNewswire
03:00PM  Investor Network: HTG Molecular Diagnostics, Inc. to Host Earnings Call Accesswire
May-04-17 08:30AM  HTG Molecular Diagnostics Introduces HTG EdgeSeq PATH Assay to Launch in Second Quarter 2017 GlobeNewswire -11.21%
May-01-17 04:01PM  HTG Molecular Diagnostics to Hold 2017 First Quarter Results Conference Call on May 15, 2017 GlobeNewswire
03:59PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : May 1, 2017 Capital Cube
Apr-24-17 08:00AM  HTG Molecular Diagnostics and Instituto Valenciano de Oncología Initiate Breast Cancer Recurrence Risk Collaboration GlobeNewswire
Apr-17-17 04:01PM  HTG Molecular Diagnostics Transfers Listing to The Nasdaq Capital Market GlobeNewswire
12:55PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : April 17, 2017 Capital Cube
08:00AM  HTG Molecular Diagnostics and Centre Léon Bérard Enter Into Molecular Profiling Research Agreement GlobeNewswire
07:30AM  HTG Molecular Diagnostics and Daiichi Sankyo Complete Master Services Agreement GlobeNewswire
Apr-05-17 04:52PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : April 5, 2017 Capital Cube
Apr-04-17 09:15AM  Today's Research Reports on Stocks to Watch: TearLab and HTG Molecular Diagnostics Accesswire -10.37%
Mar-30-17 10:21AM  The Bears Continue to Be Frustrated TheStreet.com +11.60%
Mar-29-17 01:04PM  HTG MOLECULAR DIAGNOSTICS, INC Financials -10.27%
12:49PM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017 Capital Cube
10:21AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: 2016 By the Numbers : March 29, 2017
Mar-28-17 06:07AM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Regulation FD Disclosure -23.56%
Mar-24-17 02:46PM  HTG Molecular's Shares Soar 450% the Past Two Days The Wall Street Journal +145.55%
09:30AM  Advances in Healthcare Technology and Osteoarthritis Drug Therapies Propel Two Healthcare Stocks Accesswire
09:21AM  Edited Transcript of HTGM earnings conference call or presentation 23-Mar-17 9:00pm GMT Thomson Reuters StreetEvents
Mar-23-17 05:00PM  HTG Molecular Diagnostics Inc Earnings Call scheduled for 5:00 pm ET today +83.64%
04:07PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
04:03PM  HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results GlobeNewswire
04:01PM  HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN GeneReader NGS System GlobeNewswire
12:10PM  HTG Molecular Cancer Diagnostic Test Gets CE Mark Investopedia
10:05AM  How a Key European Decision Is Making All the Difference at HTG
07:56AM  HTG Molecular's stock soars again after CE mark obtained for assay used in lung tumor analysis at MarketWatch
07:07AM  Q4 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close
Mar-22-17 04:01PM  HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU GlobeNewswire +8.63%
Mar-21-17 07:00AM  HTG Molecular Diagnostics to Hold 2016 Fourth Quarter and Full Year Financial Results Conference Call on March 23, 2017 GlobeNewswire -7.94%
Mar-07-17 04:20PM  HTG Molecular Diagnostics Appoints New Chair of the Board of Directors GlobeNewswire -8.55%
04:01PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers
Feb-27-17 07:00AM  HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017 GlobeNewswire +158.54%
Feb-21-17 04:01PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Jan-05-17 04:01PM  HTG Molecular Diagnostics Completes Module Three Filing for HTG EdgeSeq ALKPlus Assay PMA GlobeNewswire -5.12%
Dec-16-16 11:45AM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 16, 2016
Dec-02-16 12:33PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : December 2, 2016
Nov-18-16 11:13AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
Nov-17-16 06:10AM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of E
Nov-16-16 08:30AM  HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics GlobeNewswire +11.73%
Nov-14-16 04:30PM  HTG Molecular Diagnostics Inc Earnings Call scheduled for 4:30 pm ET today
04:17PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
04:01PM  HTG Molecular Diagnostics Reports Third Quarter 2016 Results GlobeNewswire
07:07AM  Q3 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close
Nov-03-16 04:01PM  HTG Molecular Diagnostics to Hold 2016 Third Quarter Financial Results Conference Call on November 14, 2016 GlobeNewswire -5.24%
Nov-02-16 04:01PM  HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum GlobeNewswire -5.41%
Nov-01-16 12:03PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : November 1, 2016
Oct-18-16 10:32AM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : October 18, 2016 -12.33%
Oct-12-16 01:22PM  Todays Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More at Insider Monkey +37.17%
Oct-11-16 05:43PM  UPDATE HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter Into a Master Companion Diagnostics Agreement GlobeNewswire
04:01PM  HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter Into a Master Companion Diagnostics Agreement GlobeNewswire
Sep-20-16 10:29AM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : September 20, 2016
Aug-30-16 04:41PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters t
Aug-29-16 04:01PM  Dr. Ann Hanham Joins HTG Molecular Diagnostics Board of Directors GlobeNewswire
Aug-27-16 10:20AM  7 Analyst Stocks Under $10 With Massive Upside at 24/7 Wall St.
Aug-23-16 11:58AM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : August 23, 2016
Aug-22-16 10:18AM  HTG Molecular's Profiling System 'Requires Less But Delivers More'
07:06AM  Coverage initiated on HTG Molecular Diagnostics by Rodman & Renshaw
Aug-19-16 04:07PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Aug-12-16 11:41AM  HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-10-16 03:11PM  Edited Transcript of HTGM earnings conference call or presentation 9-Aug-16 8:30pm GMT
Aug-09-16 04:30PM  HTG Molecular Diagnostics Inc Earnings Call scheduled for 4:30 pm ET today
04:14PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
04:01PM  HTG Molecular Diagnostics Reports Second Quarter 2016 Results GlobeNewswire
07:07AM  Q2 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close
Jul-28-16 04:05PM  HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference GlobeNewswire
04:01PM  HTG Molecular Diagnostics to Hold 2016 Second Quarter Financial Results Conference Call on August 9, 2016 GlobeNewswire
Jul-20-16 04:01PM  HTG Molecular Diagnostics Obtains CE IVD Mark for Its HTG EdgeSeq DLBCL Cell of Origin Assay and HTG EdgeSeq System GlobeNewswire
12:33PM  ETFs with exposure to HTG Molecular Diagnostics, Inc. : July 20, 2016
Jul-06-16 04:01PM  HTG Molecular Diagnostics and Firalis Announce Agreement to Develop a Theranostic Tool to Predict Response to Anti-TNF-alpha Therapies for Rheumatoid Arthritis GlobeNewswire
Jun-23-16 04:01PM  HTG Molecular Diagnostics Announces VERI/O Laboratory Service GlobeNewswire -7.77%
Jun-20-16 04:01PM  HTG Molecular Appoints New Vice President of North American Capital Sales for the HTG EdgeSeq Platform GlobeNewswire +5.49%
Jun-06-16 08:00AM  HTG Molecular Diagnostics and Cancer Genetics Announce Presentation of an Immuno-Oncology Study at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting GlobeNewswire +7.67%
Jun-01-16 04:07PM  HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers
HTG Molecular Diagnostics, Inc. develops and markets products and services based on proprietary technology that facilitates the routine use of targeted molecular profiling. The company's products, HTG Edge and HTG EdgeSeq platforms include instrumentation (or platforms), consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's assay product offerings include HTG EdgeSeq oncology biomarker panel; HTG EdgeSeq immuno-oncology assay; HTG EdgeSeq lymphoma panel; HTG EdgeSeq microRNA whole-transcriptome assay; and HTG EdgeSeq DLBCL cell of origin assay. It also provides sample processing and molecular profiling of retrospective cohorts through its VERI/O laboratory; and designs custom panels for biopharmaceutical customers and research services, resulting from research and development collaboration agreements with biopharmaceutical customers. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company has a research collaboration with Insituto Valenciano de Oncologia on breast cancer recurrence risk. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novo Holdings A/S10% OwnerAug 25Sale1.75720,2141,260,5910Aug 25 07:17 PM
Novo Holdings A/S10% OwnerAug 24Sale1.91382,437729,919720,214Aug 25 07:17 PM
Novo Holdings A/S10% OwnerAug 23Sale2.0247,16295,4751,102,651Aug 25 07:17 PM
Novo Holdings A/S10% OwnerAug 22Sale2.0112,64125,4121,199,599Aug 22 07:25 PM
Novo Holdings A/S10% OwnerAug 21Sale2.0212,84525,9761,212,240Aug 22 07:25 PM
Novo Holdings A/S10% OwnerAug 18Sale2.1055,100115,6001,225,085Aug 22 07:25 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerMar 27Sale10.15300,0003,045,180792,781Mar 29 04:04 PM
open in yahoo | open in reuters | open in google